Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
When hospitals, insurers, and pharmacies merge, patients pay more. Vertical integration — where one company controls multiple parts of the healthcare supply chain — is driving up costs and limiting patient choice at a rapid pace. Studies show patients end up with higher bills and no better health outcomes, and regulators are struggling to keep up.
When one company owns the hospital, the doctor's office, the surgery center, and the pharmacy, patients often have little say in where — or how expensively — they receive care. That's the reality of vertical integration in U.S. healthcare, and it's accelerating fast. A radiology professor's simple polyp removal ballooned from a ~$3,000 in-office procedure to a ~$6,000 surgery center visit overnight — simply because her doctor's practice had been acquired by a hospital system that directed her elsewhere.
Today, 82% of physicians are employed by hospitals, corporate entities, or private equity firms — more than double the share from a decade ago. Major insurers like UnitedHealth, CVS/Aetna, and Cigna have absorbed pharmacy benefit managers, specialty pharmacies, and physician practices, creating closed ecosystems where patients are funneled to higher-cost, in-network services. Copay assistance from drug manufacturers is often captured by insurers rather than applied to patient deductibles.
By the Numbers:
Why it matters: Antitrust regulators are under-resourced and largely reactive, catching only a fraction of consolidation deals. Without systemic reforms — like site-neutral payment policies — patients will continue absorbing the financial consequences of a healthcare market increasingly designed around corporate efficiency, not patient care.
